Louis Aledort is a board-certified internist and hematologist who began his Mount Sinai career in 1966. A former Dean for Faculty and Hospital Affairs at Mount Sinai School of Medicine, Dr. Aledort has been The Mary Weinfeld Professor of Clinical Research in Hemophilia since 1993.
Dr. Aledort earned his medical degree at the Albert Einstein College of Medicine of Yeshiva University as a member of its first graduating class, in 1959. He continued his studies as a resident at the University of Virginia and at Strong Memorial Hospital in Rochester, NY, where he also had a Hematology Fellowship. From Rochester, Dr. Aledort joined Mount Sinai, where he has remained for 45 years.
A pioneer in the study and treatment of coagulation disorders, Dr. Aledort continues to be the one of the world’s leading authorities on hemophilia. He has long been at the forefront of developing comprehensive care for hemophilia, including creating The Mount Sinai Regional Comprehensive Hemophilia Treatment Center, which has been designated as a World Health Organization Global Cooperating Training Center in Coagulation Diseases. He has been involved in this field for over 50 years, through his academic research and community and service efforts.
Dr. Aledort has been a leader in the design and implementation of several groundbreaking collaborative study groups, including the U.S. Hemophilia Study Group, the Transfusion Safety Study, and the Orthopedic Outcome Study. He has authored more than 400 peer-reviewed articles in prominent journals, including Haemophilia, Journal of Thrombosis and Haemostasis, and the American Journal of Hematology.
Dr. Aledort's research interests include: White cell disorders, Red cell disorders, Platelet disorders, Vasculitis, Thrombosis, and Bleeding.
- Editorial: J Blood Res Hematol Dis 2015, 1:1
Richard T Silver and Hans Carl Hasselbalch
- Editorial: J Blood Res Hematol Dis 2016, 1:2
Theodoros P Vassilakopoulos and Sotirios G Papageorgiou
Characterization of Complex Chromosomal Rearrangements in Acute Myeloid Leukemia: FISH and Multicolor FISH Add Precision in Defining Abnormalities Associated with Poor PrognosisResearch Article: J Blood Res Hematol Dis 2016, 1:2
Pina J Trivedi, Dharmesh M Patel, Manisha M Brahmbhatt and Prabhudas S Patel
- Editorial: J Blood Res Hematol Dis 2016, 1:1
Luisa M Massimo
- Short Communication: J Blood Res Hematol Dis 2016, 1:1
Yasuhiro Maeda, Atsushi Okamoto, Shin-ichiro Kawaguchi, Akiko Konishi, Kenta Yamamoto, Go Eguchi and Terufumi Yamaguchi
- Review Article: J Blood Res Hematol Dis 2016, 1:2
Afaq Ahmad Khan, Zeeshan Ahmad Wani, Tufeel Kochak and Sonmoon Mohapatra
Autoimmune Thyroid Disease in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms Treated with Interferon-AlphaResearch Article: J Blood Res Hematol Dis 2016, 1:1
Cecilie Paulsrud, Hans C Hasselbalch and Ole Weis Bjerrum
Efficiency of Pre-Storage Leukoreduction of Red Cells: A Double Blind Quality Control Method, Transfusion medicineLetter to Editor: J Blood Res Hematol Dis 2016, 1:2
Setia Rasika, Arora Satyam, Handoo Anil and Kapoor Meenu
Timely Dosage Dependent Ethanolic Extract of Mangifera Indica Promotes Blood Cells Development and Weight GainResearch Article: J Blood Res Hematol Dis 2016, 1:2
Jimmy EO and Udo ES
- Review Article: J Blood Res Hematol Dis 2016, 1:1
Teresa Sadras, Richard J D’Andrea and Deborah L White